Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.

about

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan.

P2860

Q47103078-9534E378-8604-4695-AF49-DF0807933194

P2860

Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.

Item

http://www.wikidata.org/entity/Q38682430

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Metformin is associated with f ...... core-matched nationwide study.

@en

type

Item

label

Metformin is associated with f ...... core-matched nationwide study.

@en

prefLabel

Metformin is associated with f ...... core-matched nationwide study.

@en

P1476

Metformin is associated with f ...... core-matched nationwide study.

@en

P2093

Cheng-Hung Lee

http://www.w3.org/2001/XMLSchema#string

Chi-Tai Kuo

http://www.w3.org/2001/XMLSchema#string

Jia-Rou Liu

http://www.w3.org/2001/XMLSchema#string

Kuang-Tso Lee

http://www.w3.org/2001/XMLSchema#string

Lung-Sheng Wu

http://www.w3.org/2001/XMLSchema#string

Ming-Shien Wen

http://www.w3.org/2001/XMLSchema#string

Shang-Hung Chang

http://www.w3.org/2001/XMLSchema#string

Yung-Hsin Yeh

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

10-year follow-up of intensive glucose control in type 2 diabetes

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies.

Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes

Metformin use and mortality in ambulatory patients with diabetes and heart failure.

Metformin use and mortality among patients with diabetes and atherothrombosis.

P304

e7507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000007507

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lai-Chu See

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28700501

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

5515773

http://www.w3.org/2001/XMLSchema#string

Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.

about

P2860

P2860

Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932